Compare Carlyle Group Inc (CG) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carlyle Group Inc vs Cassava Sciences Inc — how do they compare? Carlyle Group Inc trades at $48.27 (market cap $17.23B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Carlyle Group Inc is far larger — about 360.8× Cassava Sciences Inc's market cap, and Carlyle Group Inc pays a 2.9% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| CG | FLNA | |
|---|---|---|
Market Cap | $17.23B | $47.75M |
Sector | Financials | Health |
52-Week High | $69.35 | $4.64 |
52-Week Low | $40.52 | $0.87 |
Dividend Yield | 2.9% | — |
Enterprise Value | — | -$34.93M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Carlyle Group Inc
The Carlyle Group is one of the world's largest alternative-asset managers, with $376.4 billion in total assets under management, including $259.6 billion in fee-earning AUM, at the end of June 2022. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure and natural resources funds (accounting for 41% of fee-earning AUM and 65% of base management fees during 2021), global credit (45% and 24%) and investment solutions (14% and 11%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving close to 2,700 active carry fund investors from 95 countries.
Read more on CG →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
